Concept information
Preferred term
6-Ketoprostaglandin F1 alpha
Type
-
mesh:Descriptor
Definition
- The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.
Broader concept
Entry terms
- 58962-34-8
- 6-Keto-PGF1 alpha
- 6 Ketoprostaglandin F1 alpha
- 6-Oxo-PGF1 alpha
- 6-Oxoprostaglandin F1 alpha
- Prost-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9alpha,11alpha,13E,15S)-
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- deficiency (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- physiology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
58962-34-8
-
6-céto-PG-F1 alpha
-
6-céto-PGF1 alpha
-
6-céto-PGF1alpha
-
6-cétoprostaglandine Flalpha
-
6-oxo-PG-F1 alpha
-
6-Oxo-PGF1 alpha
-
6-oxo-PGF1alpha
-
6-Oxoprostaglandine F1 alpha
-
6-Oxoprostaglandine F1alpha
-
Prost-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9alpha,11alpha,13E,15S)-
URI
http://data.loterre.fr/ark:/67375/JVR-G9PNLVJ7-M
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}